Lactiga is Drug Discovery in Canada that focus on Common Variable Immunodeficiency business. Founded in 2017. They cover business area such as developer, novel therapeutic, rare immunodeficiency, biotherapeutic, mucosal infection, patient, primary immunodeficiency disease, PIDD, Selective IgA Deficiency, (SIgAD, Common Variable Immunodeficiency, CVID, immunodeficient, people, normal life, invasive treatment.
2017
( 7 years old in 2024 )
Common Variable Immunodeficiency
-
Toronto, Ontario
Canada
Private
developernovel therapeuticrare immunodeficiencybiotherapeuticmucosal infectionpatientprimary immunodeficiency diseasePIDDSelective IgA Deficiency(SIgADCommon Variable ImmunodeficiencyCVIDimmunodeficientpeoplenormal lifeinvasive treatment
* We use standard office opening hours in near Lactiga's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Lactiga is Drug Discovery business from Canada that founded in 2017 (7 years old in 2024), Lactiga business is focusing on Common Variable Immunodeficiency.
Lactiga headquarter office and corporate office address is located in Toronto, Ontario Canada.
Lactiga was founded in Canada.
In 2024, Lactiga is currently focus on Common Variable Immunodeficiency sector.
Above is snippet of Google Trends for "Common Variable Immunodeficiency" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Lactiga, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
